Hemodynamic and neurohumoral effects of
β
V. Mitrovic; W. Patyna; J. HΓΌting; M. Schlepper
π
Article
π
1991
π
Springer US
π
English
β 507 KB
The hemodynamic and neurohumoral effects of a single oral dose (0.4 mg) of the novel centrally acting antihypertensive agent moxonidine were investigated over 4 hours in ten patients with essential hypertension (WHO I-II). Pulmonary pressure indices and cardiac output were determined both at rest an